Similar articles

• Individualized magnetic resonance imaging-based neoadjuvant chemoradiation for middle and lower rectal carcinoma.

  Hermanek P, Hohenberger W, Fietkau R, Rödel C. Hermanek P, et al. Colorectal Dis. 2011 Jan;13(1):39-47. doi: 10.1111/j.1463-1318.2009.02076.x. Colorectal Dis. 2011. PMID: 19863611
• [Invasive rectal cancer treated by "neoadjuvant" radiochemotherapy: can we avoid rectal resection?].

  Ouaïssi M, Alves A, Panis Y. Ouaïssi M, et al. Ann Chir. 2006 Mar;131(3):175-6. doi: 10.1016/j.anchir.2006.01.016. Epub 2006 Feb 23. Ann Chir. 2006. PMID: 16530720 French. No abstract available.
• [Advantages of neoadjuvant therapy in rectal neoplasm].

  Nano M, Ferronato M, Solej M, D'Amico S. Nano M, et al. G Chir. 2008 May;29(5):197-202. G Chir. 2008. PMID: 18507953 Review. Italian. No abstract available.
• [Neoadjuvant radiochemotherapy for rectal cancer].

  Zehentmayr F, Wolf M, Weissenborn Y, Feldmann HJ, Belka C. Zehentmayr F, et al. MMW Fortschr Med. 2011 Sep 1;153(35):31-3. MMW Fortschr Med. 2011. PMID: 21916302 German. No abstract available.
• Adjuvant and neoadjuvant radiation therapy for rectal cancer.

  Bosset JF, Mantion G, Lorchel F, Magnin V, Pelissier EP, Gerard JP, Horiot JC. Bosset JF, et al. Semin Oncol. 2000 Oct;27(5 Suppl 10):60-5. Semin Oncol. 2000. PMID: 11049034 Review. No abstract available.